We are live on ! Find out more
ACER

Acer Therapeutics Inc
ACER

Delisted

ACER was delisted on the 8th of November, 2023.

Back to rankings

29 hedge funds and large institutions have $92.3M invested in Acer Therapeutics Inc in 2018 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 9 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

493% more capital invested

Capital invested by funds: $15.6M → $92.3M (+$76.7M)

300% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 4

71% more funds holding

Funds holding: 17 → 29 (+12)

Holders
29
Holders Change
+12
Holders Change %
+70.59%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
9
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
+$15.2M
2
NCM
Nantahala Capital Management
Connecticut
+$11.8M
3
DCM
Driehaus Capital Management
Illinois
+$11.4M
4
ACA
Avoro Capital Advisors
New York
+$7.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$6.21M

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$1.64M
2
JGC
J. Goldman & Co
New York
-$879K
3
AIS
Accurate Investment Solutions
Pennsylvania
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$21.3M +$11.8M +441,136 +176%
VC
2
Vivo Capital
California
$17.4M +$15.2M +565,579 New
DCM
3
Driehaus Capital Management
Illinois
$13.1M +$11.4M +424,046 New
ACA
4
Avoro Capital Advisors
New York
$8.63M +$7.5M +280,000 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$7.53M +$6.21M +231,822 +1,898%
HA
6
Heartland Advisors
Wisconsin
$6.48M +$1.5M +56,000 +36%
EMFAT
7
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.85M +$3.35M +125,000 New
ACP
8
Acuta Capital Partners
California
$3.37M – – –
GPP
9
Great Point Partners
Connecticut
$1.8M +$1.57M +58,461 New
Invesco
10
Invesco
Georgia
$1.25M +$1.08M +40,382 New
MWNA
11
Marshall Wace North America
New York
$1.23M – – –
Northern Trust
12
Northern Trust
Illinois
$980K +$851K +31,775 New
Geode Capital Management
13
Geode Capital Management
Massachusetts
$969K +$842K +31,439 New
EI
14
EAM Investors
California
$671K +$583K +21,773 New
AAP
15
Ardsley Advisory Partners
Connecticut
$617K – – –
6CM
16
683 Capital Management
New York
$597K +$519K +19,367 New
Two Sigma Investments
17
Two Sigma Investments
New York
$482K +$419K +15,634 New
MIM
18
Monashee Investment Management
Massachusetts
$350K – – –
Renaissance Technologies
19
Renaissance Technologies
New York
$346K +$301K +11,235 New
BlackRock
20
BlackRock
New York
$327K +$75.1K +2,805 +36%
First Manhattan
21
First Manhattan
New York
$277K +$107K +4,000 +80%
JP Morgan Chase
22
JP Morgan Chase
New York
$268K +$232K +8,659 +19,242%
Wells Fargo
23
Wells Fargo
California
$162K +$12.6K +470 +10%
Morgan Stanley
24
Morgan Stanley
New York
$98K +$85.5K +3,191 +19,944%
UBS Group
25
UBS Group
Switzerland
$70K +$22.7K +847 +59%
1
2

ACER Hedge Fund Activity: Q3 2018 in Review

29 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc (ACER) for Q3 2018, worth a combined $92.3M — up 493% from $15.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ACER positions and 4 closed out — a net gain of 12 holders — while 9 added to existing stakes and 0 trimmed.

The largest buyer was Vivo Capital, opening a new position worth an estimated $15.2M. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $1.64M sold.

  • 29 institutional investors held Acer Therapeutics Inc (ACER) as of Q3 2018, up from 17 in Q2 2018.
  • Funds reported $92.3M of Acer Therapeutics Inc stock for Q3 2018, up 493% quarter-over-quarter.
  • 16 funds opened new Acer Therapeutics Inc positions in Q3 2018 and 4 closed out, a net change of +12 holders.
  • The largest Acer Therapeutics Inc buyer in Q3 2018 was Vivo Capital, an estimated $15.2M added.
  • The largest Acer Therapeutics Inc seller in Q3 2018 was Alyeska Investment Group, an estimated $1.64M sold.

Based on aggregated 13F filings for Q3 2018.